18 December 2024
18 December 2024
Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.
Improper advertising on media constituted a large part of traffic directed to the companies’ websites.
However, caution persists: 166 of 785 US venture-backed companies with an innovator drug in development have not raised capital since 2021.
Terray is set to leverage its platform to identify and develop compounds for targets chosen by Gilead.
Oncology research and development is a hotbed of activity. But with new therapeutic approaches come new challenges; what are these challenges, and how are leaders in the space responding?
The NMPA decision follows US approval in October 2023, based on the outcomes from the KEYNOTE-671 trial.
Lilly has been instrumental in supplying its API for insulin at a low cost and offering technology transfer to EVA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
